• Citer

Adjuvant trastuzumab in elderly with HER-2 positive breast cancer: a systematic review of randomized controlled trials.

par Brollo, Janaina;Curigliano, Giuseppe;Disalvatore, Davide;Marrone, Bianca Fontana;Criscitiello, Carmen ;Bagnardi, Vincenzo;Kneubil, Maximiliano Cassilha;Fumagalli, Luca;Locatelli, Marzia;Manunta, Silvia;Goldhirsch, Aron
Référence Cancer treatment reviews, 39, 1, page (44-50)
Publication Publié, 2013-02

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Adjuvant trastuzumab in elderly with HER-2 positive breast cancer: a systematic review of randomized controlled trials.
Auteur:	Brollo, Janaina; Curigliano, Giuseppe; Disalvatore, Davide; Marrone, Bianca Fontana; Criscitiello, Carmen; Bagnardi, Vincenzo; Kneubil, Maximiliano Cassilha; Fumagalli, Luca; Locatelli, Marzia; Manunta, Silvia; Goldhirsch, Aron
Informations sur la publication:	Cancer treatment reviews, 39, 1, page (44-50)
Statut de publication:	Publié, 2013-02
Sujet CREF:	Cancérologie
MeSH keywords:	Aged
	Aged, 80 and over
	Antibodies, Monoclonal, Humanized -- administration & dosage
	Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
	Breast Neoplasms -- drug therapy -- enzymology
	Chemotherapy, Adjuvant
	Female
	Geriatrics -- methods
	Humans
	Middle Aged
	Randomized Controlled Trials as Topic
	Receptor, erbB-2 -- biosynthesis
Note générale:	Journal Article
	Meta-Analysis
	Review
Langue:	Anglais
Identificateurs:	urn:issn:0305-7372
	info:doi/10.1016/j.ctrv.2012.03.009
	info:pii/S0305-7372(12)00075-8
	info:pmid/22541668